Opaleye Management Inc. Opti Nose, Inc. Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.82 $160,107 - $347,505	90,970 New	90,970 $333,000
Q4 2021 Feb 14, 2022	SELL	$1.55 - $3.1 $2.42 Million - $4.83 Million	-1,558,500 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$2.35 - $3.16 $779,965 - $1.05 Million	331,900 Added 27.06%	1,558,500 $4.68 Million
Q2 2021 Aug 16, 2021	BUY	$2.91 - $3.83 $1.17 Million - $1.53 Million	400,600 Added 48.5%	1,226,600 $3.82 Million
Q1 2021 May 18, 2021	BUY	$3.47 - $4.75 $1.36 Million - $1.86 Million	391,000 Added 89.89%	826,000 $3.05 Million
Q4 2020 Feb 12, 2021	BUY	$3.2 - $4.98 $1.39 Million - $2.17 Million	435,000 New	435,000 $1.8 Million

85.6M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $484M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.